Peer-influenced content. Sources you trust. No registration required. This is HCN.

Features:
CME JOBS OUTBREAKS PEER-TO-PEER QUIZZES & QUESTIONS MEDTECH

Articles related to ARRYTHMIA

NEJM Evidence

Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-Ds

A recent randomized controlled trial found that ertugliflozin treatment was associated with a significant reduction in the yearly rate of sustained ventricular arrhythmias (3.5 vs 13.3 events) compared to placebo in patients with heart failure and implantable cardioverter-defibrillators.

Cardiology September 30th 2024

Tags: ARRYTHMIA DEFIBRILLATORS ELECTROPHYSIOLOGY HEART FAILURE (HF) SGLT2 INHIBITORS

Topics

Sources

ACP Internist
Annals of Internal Medicine
ASH Clinical News
Blood
Blood Advances
British Medical Journal (The BMJ)
Cancer Therapy Advisor
Cleveland Clinic Journal of Medicine
Clinical Advances in Hematology & Oncology
GoodRx Health
Healthgrades for Professionals
JAMA Network
Journal of Clinical Oncology
MDLinx
MedPage Today
Medical Professionals Reference (MPR)
Neurology Advisor
Psychiatrist.com
ReachMD
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form